Annovis Bio
ANVS
12 hedge funds and large institutions have $1.52M invested in Annovis Bio in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more funds holding
Funds holding: 8 → 12 (+4)
43% more capital invested
Capital invested by funds: $1.06M → $1.52M (+$458K)
1.04% more ownership
Funds ownership: 3.55% → 4.59% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
+$273K |
| 2 |
IA
Independence Advisors
Wayne,
Pennsylvania
|
+$244K |
| 3 |
Renaissance Technologies
New York
|
+$110K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$91.9K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$80K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$166K |
| 2 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
-$120K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$107K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$65K |
| 5 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$52K |
ANVS Hedge Fund Activity: Q3 2020 in Review
12 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2020, worth a combined $1.52M — up 43% from $1.06M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ANVS positions and 4 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Sterling Investment Advisors (Pennsylvania), opening a new position worth an estimated $273K. The largest seller was Millennium Management, exiting entirely with an estimated $166K sold.
- 12 institutional investors held Annovis Bio (ANVS) as of Q3 2020, up from 8 in Q2 2020.
- Funds reported $1.52M of Annovis Bio stock for Q3 2020, up 43% quarter-over-quarter.
- 8 funds opened new Annovis Bio positions in Q3 2020 and 4 closed out, a net change of +4 holders.
- The largest Annovis Bio buyer in Q3 2020 was Sterling Investment Advisors (Pennsylvania), an estimated $273K added.
- The largest Annovis Bio seller in Q3 2020 was Millennium Management, an estimated $166K sold.
Based on aggregated 13F filings for Q3 2020.